SMAD4
Summary: This gene encodes a member of the Smad family of signal transduction proteins. Smad proteins are phosphorylated and activated by transmembrane serine-threonine receptor kinases in response to transforming growth factor (TGF)-beta signaling. The product of this gene forms homomeric complexes and heteromeric complexes with other activated Smad proteins, which then accumulate in the nucleus and regulate the transcription of target genes. This protein binds to DNA and recognizes an 8-bp palindromic sequence (GTCTAGAC) called the Smad-binding element (SBE). The protein acts as a tumor suppressor and inhibits epithelial cell proliferation. It may also have an inhibitory effect on tumors by reducing angiogenesis and increasng blood vessel hyperpermeability. The encoded protein is a crucial component of the bone morphogenetic protein signaling pathway. The Smad proteins are subject to complex regulation by post-translational modifications. Mutations or deletions in this gene have been shown to result in pancreatic cancer, juvenile polyposis syndrome, and hereditary hemorrhagic telangiectasia syndrome. [provided by RefSeq, Aug 2017].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
SMAD family member 4 | MIM:600993 | Ensembl:ENSG00000141646 | HGNC:HGNC:6770 | PA30527 | 18q21.2 |
GO terms in SMAD4
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IDA | GO:0000978 | RNA polymerase II proximal promoter sequence-specific DNA binding |
MF | ISA | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
MF | ISM | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
MF | NAS | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
MF | IDA | GO:0000987 | proximal promoter sequence-specific DNA binding |
MF | IDA | GO:0000989 | transcription factor activity, transcription factor binding |
MF | IDA | GO:0001077 | transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding |
MF | IEA | GO:0001085 | RNA polymerase II transcription factor binding |
MF | IDA | GO:0003677 | DNA binding |
MF | IEA | GO:0003682 | chromatin binding |
MF | IDA | GO:0003700 | DNA-binding transcription factor activity |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0005518 | collagen binding |
MF | IDA | GO:0030616 | transforming growth factor beta receptor, common-partner cytoplasmic mediator activity |
MF | IMP | GO:0042802 | identical protein binding |
MF | IPI | GO:0042802 | identical protein binding |
MF | IPI | GO:0042803 | protein homodimerization activity |
MF | IMP | GO:0043199 | sulfate binding |
MF | IDA | GO:0043565 | sequence-specific DNA binding |
MF | IDA | GO:0044212 | transcription regulatory region DNA binding |
MF | IEA | GO:0046872 | metal ion binding |
MF | IEA | GO:0046982 | protein heterodimerization activity |
MF | IPI | GO:0070411 | I-SMAD binding |
MF | IPI | GO:0070412 | R-SMAD binding |
CC | IDA | GO:0000790 | nuclear chromatin |
CC | IDA | GO:0005634 | nucleus |
CC | IDA | GO:0005654 | nucleoplasm |
CC | TAS | GO:0005654 | nucleoplasm |
CC | IDA | GO:0005667 | transcription factor complex |
CC | IPI | GO:0005667 | transcription factor complex |
CC | IDA | GO:0005737 | cytoplasm |
CC | IDA | GO:0005813 | centrosome |
CC | IDA | GO:0005829 | cytosol |
CC | TAS | GO:0005829 | cytosol |
CC | IDA | GO:0032444 | activin responsive factor complex |
CC | IDA | GO:0071141 | SMAD protein complex |
CC | IMP | GO:0071141 | SMAD protein complex |
BP | ISS | GO:0000122 | negative regulation of transcription by RNA polymerase II |
BP | TAS | GO:0000122 | negative regulation of transcription by RNA polymerase II |
BP | IEA | GO:0001541 | ovarian follicle development |
BP | IEA | GO:0001658 | branching involved in ureteric bud morphogenesis |
BP | IMP | GO:0001666 | response to hypoxia |
BP | IEA | GO:0001701 | in utero embryonic development |
BP | IEA | GO:0001702 | gastrulation with mouth forming second |
BP | ISS | GO:0003148 | outflow tract septum morphogenesis |
BP | IEA | GO:0003190 | atrioventricular valve formation |
BP | IEA | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation |
BP | ISS | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis |
BP | IEA | GO:0003251 | positive regulation of cell proliferation involved in heart valve morphogenesis |
BP | IEA | GO:0003360 | brainstem development |
BP | ISS | GO:0006879 | cellular iron ion homeostasis |
BP | IDA | GO:0007179 | transforming growth factor beta receptor signaling pathway |
BP | ISS | GO:0007179 | transforming growth factor beta receptor signaling pathway |
BP | TAS | GO:0007179 | transforming growth factor beta receptor signaling pathway |
BP | IDA | GO:0007183 | SMAD protein complex assembly |
BP | IEA | GO:0007283 | spermatogenesis |
BP | IEA | GO:0007338 | single fertilization |
BP | IEA | GO:0007411 | axon guidance |
BP | IEA | GO:0007492 | endoderm development |
BP | IEA | GO:0007498 | mesoderm development |
BP | IEA | GO:0008283 | cell proliferation |
BP | IEA | GO:0008285 | negative regulation of cell proliferation |
BP | ISS | GO:0010614 | negative regulation of cardiac muscle hypertrophy |
BP | ISS | GO:0010718 | positive regulation of epithelial to mesenchymal transition |
BP | ISS | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation |
BP | IEA | GO:0014033 | neural crest cell differentiation |
BP | TAS | GO:0016579 | protein deubiquitination |
BP | IMP | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway |
BP | IDA | GO:0030308 | negative regulation of cell growth |
BP | IDA | GO:0030509 | BMP signaling pathway |
BP | ISS | GO:0030509 | BMP signaling pathway |
BP | TAS | GO:0030509 | BMP signaling pathway |
BP | IDA | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway |
BP | IMP | GO:0030513 | positive regulation of BMP signaling pathway |
BP | IEA | GO:0032525 | somite rostral/caudal axis specification |
BP | IMP | GO:0032909 | regulation of transforming growth factor beta2 production |
BP | IEA | GO:0033686 | positive regulation of luteinizing hormone secretion |
BP | TAS | GO:0035019 | somatic stem cell population maintenance |
BP | IMP | GO:0035556 | intracellular signal transduction |
BP | IEA | GO:0036302 | atrioventricular canal development |
BP | IEA | GO:0042118 | endothelial cell activation |
BP | IEA | GO:0042733 | embryonic digit morphogenesis |
BP | IDA | GO:0045892 | negative regulation of transcription, DNA-templated |
BP | IDA | GO:0045893 | positive regulation of transcription, DNA-templated |
BP | IDA | GO:0045944 | positive regulation of transcription by RNA polymerase II |
BP | ISS | GO:0045944 | positive regulation of transcription by RNA polymerase II |
BP | TAS | GO:0045944 | positive regulation of transcription by RNA polymerase II |
BP | IEA | GO:0046881 | positive regulation of follicle-stimulating hormone secretion |
BP | IEA | GO:0048589 | developmental growth |
BP | IEA | GO:0048663 | neuron fate commitment |
BP | IEA | GO:0048733 | sebaceous gland development |
BP | IEA | GO:0048859 | formation of anatomical boundary |
BP | IEA | GO:0051098 | regulation of binding |
BP | ISS | GO:0051571 | positive regulation of histone H3-K4 methylation |
BP | IEA | GO:0051797 | regulation of hair follicle development |
BP | IEA | GO:0060065 | uterus development |
BP | ISS | GO:0060391 | positive regulation of SMAD protein signal transduction |
BP | IDA | GO:0060395 | SMAD protein signal transduction |
BP | ISS | GO:0060412 | ventricular septum morphogenesis |
BP | IEA | GO:0060548 | negative regulation of cell death |
BP | IEA | GO:0060956 | endocardial cell differentiation |
BP | IEA | GO:0061040 | female gonad morphogenesis |
BP | IEA | GO:0061614 | pri-miRNA transcription by RNA polymerase II |
BP | ISS | GO:0062009 | secondary palate development |
BP | ISS | GO:0070102 | interleukin-6-mediated signaling pathway |
BP | IMP | GO:0070207 | protein homotrimerization |
BP | ISS | GO:0070373 | negative regulation of ERK1 and ERK2 cascade |
BP | IDA | GO:0071559 | response to transforming growth factor beta |
BP | NAS | GO:0071773 | cellular response to BMP stimulus |
BP | IEA | GO:0072133 | metanephric mesenchyme morphogenesis |
BP | IEA | GO:0072134 | nephrogenic mesenchyme morphogenesis |
BP | IEA | GO:0072520 | seminiferous tubule development |
BP | TAS | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus |
BP | ISS | GO:1905305 | negative regulation of cardiac myofibril assembly |
BP | ISS | GO:2000617 | positive regulation of histone H3-K9 acetylation |
Gene expression in normal tissue: SMAD4
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in SMAD4
Database | Pathway ID | Pathway Des. |
---|---|---|
wikipathways | WP138 | Androgen receptor signaling pathway |
wikipathways | WP1425 | Bone Morphogenic Protein (BMP) Signalling and Regulation |
wikipathways | WP1591 | Heart Development |
wikipathways | WP179 | Cell Cycle |
wikipathways | WP2853 | Endoderm Differentiation |
wikipathways | WP2857 | Mesodermal Commitment Pathway |
wikipathways | WP2858 | Ectoderm Differentiation |
wikipathways | WP2870 | Extracellular vesicle-mediated signaling in recipient cells |
wikipathways | WP3646 | Hepatitis C and Hepatocellular Carcinoma |
wikipathways | WP3657 | Hematopoietic Stem Cell Gene Regulation by GABP alpha-beta Complex |
wikipathways | WP366 | TGF-beta Signaling Pathway |
wikipathways | WP3668 | Hypothesized Pathways in Pathogenesis of Cardiovascular Disease |
wikipathways | WP3859 | TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition |
wikipathways | WP3874 | Canonical and Non-Canonical TGF-B signaling |
wikipathways | WP3927 | BMP Signaling Pathway in Eyelid Development |
wikipathways | WP3931 | ESC Pluripotency Pathways |
wikipathways | WP4216 | Chromosomal and microsatellite instability in colorectal cancer |
wikipathways | WP4239 | EMT transition in Colorectal Cancer |
wikipathways | WP560 | TGF-beta Receptor Signaling |
wikipathways | WP615 | Senescence and Autophagy in Cancer |
wikipathways | WP710 | DNA Damage Response (only ATM dependent) |
netpath | Pathway_TGF_beta_Receptor | TGF_beta_Receptor |
pid | alk1pathway | ALK1 signaling events |
pid | alk2pathway | ALK2 signaling events |
pid | bmppathway | BMP receptor signaling |
pid | era_genomic_pathway | Validated nuclear estrogen receptor alpha network |
pid | hif1_tfpathway | HIF-1-alpha transcription factor network |
pid | lkb1_pathway | LKB1 signaling events |
pid | myc_activpathway | Validated targets of C-MYC transcriptional activation |
pid | myc_represspathway | Validated targets of C-MYC transcriptional repression |
pid | smad2_3nuclearpathway | Regulation of nuclear SMAD2/3 signaling |
pid | smad2_3pathway | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
pid | tgfbrpathway | TGF-beta receptor signaling |
kegg | hsa04068 | FoxO signaling pathway - Homo sapiens (human) |
kegg | hsa04110 | Cell cycle - Homo sapiens (human) |
kegg | hsa04310 | Wnt signaling pathway - Homo sapiens (human) |
kegg | hsa04350 | TGF-beta signaling pathway - Homo sapiens (human) |
kegg | hsa04371 | Apelin signaling pathway - Homo sapiens (human) |
kegg | hsa04390 | Hippo signaling pathway - Homo sapiens (human) |
kegg | hsa04520 | Adherens junction - Homo sapiens (human) |
kegg | hsa04550 | Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human) |
kegg | hsa04659 | Th17 cell differentiation - Homo sapiens (human) |
kegg | hsa04933 | AGE-RAGE signaling pathway in diabetic complications - Homo sapiens (human) |
kegg | hsa05161 | Hepatitis B - Homo sapiens (human) |
kegg | hsa05166 | HTLV-I infection - Homo sapiens (human) |
kegg | hsa05200 | Pathways in cancer - Homo sapiens (human) |
kegg | hsa05210 | Colorectal cancer - Homo sapiens (human) |
kegg | hsa05212 | Pancreatic cancer - Homo sapiens (human) |
kegg | hsa05220 | Chronic myeloid leukemia - Homo sapiens (human) |
kegg | hsa05225 | Hepatocellular carcinoma - Homo sapiens (human) |
kegg | hsa05226 | Gastric cancer - Homo sapiens (human) |
humancyc | PWY66-11 | BMP Signalling Pathway |
biocarta | alkpathway | alk in cardiac myocytes |
biocarta | ctcfpathway | ctcf: first multivalent nuclear factor |
biocarta | g1pathway | cell cycle: g1/s check point |
biocarta | nthipathway | nfkb activation by nontypeable hemophilus influenzae |
biocarta | tgfbpathway | tgf beta signaling pathway |
biocarta | wntpathway | wnt signaling pathway |
reactome | R-HSA-1181150 | Signaling by NODAL |
reactome | R-HSA-1266738 | Developmental Biology |
reactome | R-HSA-1502540 | Signaling by Activin |
reactome | R-HSA-162582 | Signal Transduction |
reactome | R-HSA-162582 | Signal Transduction |
reactome | R-HSA-1643685 | Disease |
reactome | R-HSA-170834 | Signaling by TGF-beta Receptor Complex |
reactome | R-HSA-170834 | Signaling by TGF-beta Receptor Complex |
reactome | R-HSA-201451 | Signaling by BMP |
reactome | R-HSA-212436 | Generic Transcription Pathway |
reactome | R-HSA-212436 | Generic Transcription Pathway |
reactome | R-HSA-2173789 | TGF-beta receptor signaling activates SMADs |
reactome | R-HSA-2173793 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
reactome | R-HSA-2173793 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
reactome | R-HSA-2173795 | Downregulation of SMAD2/3:SMAD4 transcriptional activity |
reactome | R-HSA-2173795 | Downregulation of SMAD2/3:SMAD4 transcriptional activity |
reactome | R-HSA-2173796 | SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
reactome | R-HSA-3304347 | Loss of Function of SMAD4 in Cancer |
reactome | R-HSA-3304349 | Loss of Function of SMAD2/3 in Cancer |
reactome | R-HSA-3304351 | Signaling by TGF-beta Receptor Complex in Cancer |
reactome | R-HSA-3311021 | SMAD4 MH2 Domain Mutants in Cancer |
reactome | R-HSA-3315487 | SMAD2/3 MH2 Domain Mutants in Cancer |
reactome | R-HSA-392499 | Metabolism of proteins |
reactome | R-HSA-452723 | Transcriptional regulation of pluripotent stem cells |
reactome | R-HSA-5663202 | Diseases of signal transduction |
reactome | R-HSA-5688426 | Deubiquitination |
reactome | R-HSA-5689880 | Ub-specific processing proteases |
reactome | R-HSA-597592 | Post-translational protein modification |
reactome | R-HSA-73857 | RNA Polymerase II Transcription |
reactome | R-HSA-73857 | RNA Polymerase II Transcription |
reactome | R-HSA-74160 | Gene expression (Transcription) |
reactome | R-HSA-74160 | Gene expression (Transcription) |
reactome | R-HSA-8878159 | Transcriptional regulation by RUNX3 |
reactome | R-HSA-8878166 | Transcriptional regulation by RUNX2 |
reactome | R-HSA-8941326 | RUNX2 regulates bone development |
reactome | R-HSA-8941855 | RUNX3 regulates CDKN1A transcription |
reactome | R-HSA-8952158 | RUNX3 regulates BCL2L11 (BIM) transcription |
reactome | R-HSA-9006936 | Signaling by TGF-beta family members |
reactome | R-HSA-9006936 | Signaling by TGF-beta family members |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD190 | Nilotinib | 1 |
iGMDRD64 | Parbendazole | 7 |
iGMDRD524 | ISX-9 | 4 |
iGMDRD399 | Selumetinib | 7 |
iGMDRD74 | Idarubicin | 1 |
iGMDRD188 | Piperlongumine | 1 |
iGMDRD780 | PP-30 | 2 |
iGMDRD117 | Docetaxel | 2 |
iGMDRD284 | Palbociclib | 1 |
iGMDRD294 | Batimastat | 3 |
iGMDRD513 | BML-259 | 2 |
iGMDRD316 | N9-Isopropyl-olomoucine | 2 |
iGMDRD427 | ABT737 | 3 |
iGMDRD781 | Sirolimus | 1 |
iGMDRD283 | Bosutinib | 1 |
iGMDRD151 | CHM-1 | 6 |
iGMDRD126 | Tipifarnib | 2 |
iGMDRD245 | FH535 | 1 |
iGMDRD366 | PI-103 | 1 |
iGMDRD705 | Nakiterpiosin | 4 |
iGMDRD461 | VX-11e | 1 |
iGMDRD594 | AZD-8055 | 1 |
iGMDRD423 | AT 7867 | 1 |
iGMDRD1036 | X17AAG | 1 |
iGMDRD405 | PIK-75 | 1 |
iGMDRD564 | GSK-650394 | 1 |
iGMDRD324 | CI-1040 | 3 |
iGMDRD248 | BRD4354 | 4 |
iGMDRD131 | Erlotinib | 2 |
iGMDRD60 | Quinoclamine | 2 |
iGMDRD312 | Pelitinib | 2 |
iGMDRD332 | A-770041 | 1 |
iGMDRD398 | Sepantronium | 4 |
iGMDRD562 | Navitoclax | 7 |
iGMDRD577 | BIX01294 | 3 |
iGMDRD782 | DC-45-A2 | 2 |
iGMDRD441 | TW 37 | 1 |
iGMDRD491 | TAE-684 | 1 |
iGMDRD255 | SB225002 | 3 |
iGMDRD673 | LSM-1215 | 1 |
iGMDRD401 | Afatinib | 4 |
iGMDRD608 | Refametinib | 3 |
iGMDRD519 | GDC-0941 | 1 |
iGMDRD193 | Fqi1 | 2 |
iGMDRD239 | Dasatinib | 1 |
iGMDRD678 | Tubastatin A | 2 |
iGMDRD313 | Axitinib | 1 |
iGMDRD136 | Nutlin-3 | 1 |
iGMDRD112 | Methotrexate | 1 |
iGMDRD659 | Avagacestat (BMS-708163) | 1 |
iGMDRD1008 | SR-II-138A | 1 |
iGMDRD505 | Pevonedistat | 6 |
iGMDRD472 | PF-562271 | 1 |
iGMDRD353 | PD0325901 | 2 |
iGMDRD872 | BRD7137 | 3 |
iGMDRD68 | Paclitaxel | 1 |
iGMDRD459 | RO-3306 | 1 |
iGMDRD271 | Brefeldin A | 1 |
iGMDRD139 | Fumagillol | 2 |
iGMDRD901 | ELCPK | 5 |
iGMDRD351 | GW843682X | 4 |
iGMDRD456 | Crizotinib | 1 |
iGMDRD486 | Tosedostat | 1 |
iGMDRD382 | CEP-701 | 1 |
iGMDRD23 | Gossypol | 3 |
iGMDRD356 | PNU-74654 | 1 |
iGMDRD133 | Lapatinib | 2 |
iGMDRD146 | Elesclomol | 1 |
iGMDRD187 | BRD9876 | 2 |
iGMDRD260 | FQI-2 | 3 |
iGMDRD159 | 3-Chloro-L-alanine | 4 |
iGMDRD407 | Sotrastaurin | 1 |
iGMDRD748 | PHA-665752 | 1 |
iGMDRD21 | Fluorouracil | 1 |
iGMDRD639 | YK 4-279 | 4 |
iGMDRD670 | ML 210 | 2 |
iGMDRD397 | Pazopanib | 1 |
iGMDRD409 | Saracatinib | 1 |
iGMDRD433 | Lexibulin | 4 |
iGMDRD749 | ZINC6718453 | 1 |
iGMDRD889 | Compound 7d-cis | 1 |
iGMDRD12 | Bicalutamide | 2 |
iGMDRD147 | Prima-1 | 1 |
iGMDRD421 | AZD7762 | 1 |
iGMDRD871 | BRD6368 | 3 |
iGMDRD993 | QL-XII-61 | 1 |
iGMDRD662 | JQ-1 | 2 |
iGMDRD221 | Tamoxifen | 1 |
iGMDRD158 | NSC141540 | 4 |
iGMDRD293 | Bleomycin | 1 |
iGMDRD103 | SN-38 | 2 |
iGMDRD5 | Tyrphostin AG 1478 | 1 |
iGMDRD123 | Isoevodiamine | 3 |
iGMDRD154 | NSC23766 | 3 |
iGMDRD775 | NCGC00346967-01 | 1 |
iGMDRD237 | ABT-751 | 3 |
iGMDRD352 | PD-0325901 | 2 |
iGMDRD698 | Neratinib | 1 |
iGMDRD15 | Tacedinaline | 1 |
iGMDRD276 | AS 605240 | 2 |
iGMDRD533 | HSCI1_000270 | 1 |
iGMDRD444 | Tivantinib | 1 |
iGMDRD451 | Serdemetan | 1 |
iGMDRD887 | Compound 23 citrate | 2 |
iGMDRD309 | 17AAG | 2 |
iGMDRD138 | PX 12 | 1 |
iGMDRD134 | Sorafenib | 1 |
iGMDRD33 | Entinostat | 1 |
iGMDRD802 | 4-methylfasudil | 7 |
iGMDRD280 | CYTOCHALASIN B | 2 |
iGMDRD776 | QL-XI-92 | 1 |
iGMDRD253 | Vincaleukoblastine | 2 |
iGMDRD446 | LY 2183240 | 2 |
iGMDRD718 | Pyrvinium pamoate | 1 |
iGMDRD144 | NSC95397 | 2 |
iGMDRD494 | Neopeltolide | 1 |
iGMDRD400 | A-443654 | 1 |
iGMDRD42 | Vorinostat | 2 |
iGMDRD967 | Panitumumab | 1 |
iGMDRD192 | CIL56 | 3 |
iGMDRD434 | BMS-536924 | 1 |
iGMDRD6 | AM-580 | 2 |
iGMDRD551 | Ponatinib | 1 |
iGMDRD481 | Dactolisib | 2 |
iGMDRD177 | Teniposide | 4 |
iGMDRD357 | AG 14361 | 2 |
iGMDRD435 | BI-2536 | 1 |
iGMDRD317 | CCT 018159 | 1 |
iGMDRD765 | BRD-K51490254 | 1 |
iGMDRD536 | PLX-4720 | 1 |
iGMDRD84 | Lovastatin acid | 1 |
iGMDRD792 | Cetuximab | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in SMAD4